CrushSCI.com
144.9Average days
120.5Median days
68Fastest days
297Longest days
462025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

115 days

Pharmacokinetic Interaction of a Four-Drug Combination Therapy for Treating Mycobacterium abscessus Complex Infection: A Phase I Clinical Trial

Authors
Yuki Enoki; Fumika Kano; Shiho Suzuki; Yuki Igarashi; Shuhei Azekawa; Atsuho Morita; Hiromu Tanaka; Genta Nagao; Naoki Fukunaga; Kensuke Nakagawara; Masanori Kaji; Takanori Asakura; Kazuma Yagi; Koichi Fukunaga; Yasuyuki Tokuhiro; Chika Asami; Yumiko Fujii; Yukiko Matsushima; Naoki Miyazaki; Noriyuki Ishida; Kengo Nagashima; Kazuaki Matsumoto; Naoki Hasegawa; Ho NamkoongShow moreShow less
Affiliations
1. Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, Tokyo, Japan; 2. Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; 3. Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan; 4. Clinical and Translational Research Center, Keio University Hospital, Tokyo, JapanShow moreShow less
Source PDF DOI Publisher page
119 days

Pharmacokinetics and Safety of Nerandomilast in Healthy Volunteers

Authors
Dilara Jappar; Jing Wu; Ute Burkard; Ashish Sharma; Carl Coeck; Donald Zoz; Yichao YuShow moreShow less
Affiliations
1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; 3. Boehringer Ingelheim SComm, Brussels, BelgiumShow moreShow less
Source PDF DOI Publisher page
297 days

Factors Affecting Pharmacokinetics and Dosing Strategies of Polymyxin B in Multidrug-resistant Gram-negative Infected Patients with Renal Impairment: A Systematic Review with Expert Opinion

Authors
Asha K. Rajan; Vishal Shanbhag; Muhammed Rashid; Maria Ioana Onofrei; Indu Ramachandra Rao; Sohil A. Khan; Souvik Chaudhuri; Ravindra Prabhu Attur; Hassan Mitwally; Bhuvana Krishna; Vijayanarayana Kunhikatta; Surulivel Rajan; Girish ThungaShow moreShow less
Affiliations
1. Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India; 2. Department of Critical Care Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India; 3. Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, USA; 4. Clinic of Infectious Diseases, “Sf.Parascheva” Clinical Hospital of Infectious Diseases, Lasi, Romania; 5. Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India; 6. Pharmacotherapeutics and evidence-based practice, School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Australia; 7. Department of Pharmacy, Al Wakra Hospital, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar; 8. Department of Critical Care Medicine, St John’s Medical College and Hospital, Bengaluru, IndiaShow moreShow less
Source PDF DOI Publisher page
68 days

Randomized Study About Influence of Food on the Pharmacokinetics of Disulfiram Metabolites in Healthy Individuals

Authors
Gabriel P. E. Silveira; Douglas P. Pinto; Luciana F. Portela; Sheila Suarez Fontes; Juliana Almeida-Silva; Alessandra L. Viçosa; Sandra Aurora C. Perez; Marcos André Vannier-Santos; Rita Estrela; Roberto M. SaraivaShow moreShow less
Affiliations
1. Equivalence and Pharmacokinetics Service (Sefar), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 2. Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 3. Evandro Chagas Infectious Disease National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 4. Innovations in Therapies, Education and Bioproducts Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 5. Experimental Pharmacotechnics Laboratory, Department of Galenic Innovation, Institute of Drug Technology - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 6. Project Management Technical Assistance, Institute of Drug Technology - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 7. Pharmacometry Laboratory, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 8. Laboratory of Clinical Research on STD and AIDS, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, BrazilShow moreShow less
Source PDF DOI Publisher page
106 days

Pharmacokinetics of Fentanyl and Norfentanyl in a Rat Model of Fixed-Volume Hemorrhagic Shock

Authors
Paulina Stach; Kamil Skowron; Sebastian Rojek; Agnieszka Cios; Anna Wesołowska; Marilyn A. Huestis; Krzysztof GilShow moreShow less
Affiliations
1. Doctoral School of Medical and Health Sciences, Jagiellonian University-Collegium Medicum, Kraków, Poland; 2. Department of Pathophysiology, Faculty of Medicine, Medical College, Jagiellonian University, Kraków, Poland; 3. Department of Forensic Medicine, Faculty of Medicine, Medical College, Jagiellonian University, Kraków, Poland; 4. Department of Clinical Pharmacy, Faculty of Pharmacy, Medical College, Jagiellonian University, Kraków, Poland; 5. Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, USAShow moreShow less
Source PDF DOI Publisher page
116 days

Population Pharmacokinetic Modeling Study of Glibenclamide in Chinese Healthy Volunteers

Authors
Yaou Liu; Qingyu Yao; Xinhua Cui; Yimin Cui; Tianyan Zhou; Ran Xie; Xiaocong PangShow moreShow less
Affiliations
1. Department of Pharmacy, Peking University First Hospital, Beijing, China; 2. Drug Clinical Trial Institution, Beijing Key Laboratory of Clinical Pharmacology and Translation of Innovative Drugs, Peking University First Hospital, Beijing, China; 3. Institute of Clinical Pharmacology, Peking University, Beijing, China; 4. Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. The fastest paper went from submission to acceptance in 68 days (Randomized Study About Influence of Food on the Pharmacokinetics of Disulfiram Metabolites in Healthy Individuals, received 2026-04-10, accepted 2026-06-17); the slowest took 297 days. The average is 144.9 days and the median is 120.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.